about
A systematic approach to the diagnosis of suspected central nervous system lymphoma.Advances in Primary Central Nervous System Lymphoma.High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study.Biology and treatment of primary central nervous system lymphoma.Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohortPharmacotherapy of primary CNS lymphoma.Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome.Primary central nervous system lymphoma: is absence of intratumoral hemorrhage a characteristic finding on MRI?Corticosteroid sensitivity in gliomatosis cerebri delays diagnosisPerformance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.The Combined Performance of ADC, CSF CXC Chemokine Ligand 13, and CSF Interleukin 10 in the Diagnosis of Central Nervous System Lymphoma.Differential diagnosis of white matter diseases in the tropics: An overview.Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma.Conservative management of post-transplant central nervous system lymphoma.Cauda equina lymphoma--a rare presentation of primary central nervous system lymphoma: case report and literature review.The Influence of Corticosteroids on Diagnostic Accuracy of Biopsy for Primary Central Nervous System Lymphoma.EBV driven natural killer cell disease of the central nervous system presenting as subacute cognitive decline.Successful treatment of diffuse large B-cell lymphoma with clarithromycin and prednisolone.The transrepression arm of glucocorticoid receptor signaling is protective in mutant huntingtin-mediated neurodegeneration.The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphoma.Advances in the treatment of newly diagnosed primary central nervous system lymphomas.Differentiation of Enhancing Glioma and Primary Central Nervous System Lymphoma by Texture-Based Machine Learning.Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
P2860
Q30586022-E7708E68-F67E-4832-BA74-C16970F5C44EQ31007237-D8BA09A1-CDB8-4A70-9207-F82790AAE59FQ33381778-A7926B91-5589-4F41-A67D-0FB1670BC499Q33475480-C666B22F-C9B1-48B2-81B3-38435BE42DD5Q34132849-A5931AE8-E061-4C6F-A6A9-1CAEA0057F1AQ34482032-A5BC168D-EBE2-4D8C-8AAC-2E6E9803347BQ34542980-7AC2ADE0-4EBC-4BCB-A42F-E93DE888A312Q35296992-AC63FA0A-44D5-4E5D-ACD5-64292E1BC068Q35858604-31D7EED3-476F-4736-9BCA-956D7059E0E3Q36371802-E3483747-8B84-4A72-896B-449EB26C26E7Q36463751-F2D035B4-3C4E-4FF1-BF2A-B5FED1D7BF0FQ37691270-1DE11EE1-5CAB-4B67-A104-F36B522A6F3CQ37911948-E537753F-307C-43EC-BF05-5FF74C278A85Q38000077-7A162827-60E2-4704-8F6B-4A4437BA9E68Q38024390-7DDDA802-221F-4619-9CF6-9DC4FA0D118AQ39549672-8C286AF1-25B0-4560-AD23-A239EEF71A7BQ40068419-D58BA4AB-0B3D-4599-B9C5-06DBBC812B53Q40260894-3E6CC6C1-A0D2-4604-863F-89AA48C1EC63Q41244698-F8AC2E27-A2C6-43D2-8A3B-4CBDB07D1BB6Q41487891-F96E2CA1-3D15-4711-BF7C-66C9C8624CA2Q42377771-AF426984-7CE2-4447-9D6B-4F045A3F8237Q45947583-2970BAB7-981C-4824-98B1-D19E47FB820CQ50748905-15443D4C-30D5-43C0-B87D-3B595101EAC6
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Glucocorticoid treatment of primary CNS lymphoma.
@ast
Glucocorticoid treatment of primary CNS lymphoma.
@en
type
label
Glucocorticoid treatment of primary CNS lymphoma.
@ast
Glucocorticoid treatment of primary CNS lymphoma.
@en
prefLabel
Glucocorticoid treatment of primary CNS lymphoma.
@ast
Glucocorticoid treatment of primary CNS lymphoma.
@en
P356
P1476
Glucocorticoid treatment of primary CNS lymphoma.
@en
P2093
P2888
P304
P356
10.1023/A:1006254518848
P577
1999-07-01T00:00:00Z
P6179
1051673174